News & Updates
Filter by Specialty:
Bilateral movement computer games improve upper limb recovery in stroke survivors
A randomized controlled trial conducted by researchers from Hong Kong Metropolitan University, the Hong Kong Polytechnic University and the Chinese University of Hong Kong found greater improvements in upper limb sensorimotor functions among subacute stroke survivors who engaged in bilateral movement-based computer games (BMCG) vs conventional rehabilitation (CR) alone.
Bilateral movement computer games improve upper limb recovery in stroke survivors
09 Aug 2022
BP-lowering drug helps prevent Parkinson’s disease
Treatment with angiotensin receptor blockers (ARBs) appears to reduce the risk of Parkinson’s disease (PD) in patients newly diagnosed with hypertension, reports a recent study.
BP-lowering drug helps prevent Parkinson’s disease
08 Aug 2022
Cognition assessment important to ensure patient adherence to MS therapy
Adherence to disease-modifying therapies (DMT) in multiple sclerosis (MS) is dependent not only on the properties of the medications themselves, but also on the capacities of the patient, a recent study has found.
Cognition assessment important to ensure patient adherence to MS therapy
03 Aug 2022
White matter diminished in ASD teens born premature
In adolescents and young adults who screen positive for autism spectrum disorder (ASD), magnetic resonance imaging (MRI) reveals strong reductions in white matter, a new study has found.
White matter diminished in ASD teens born premature
29 Jul 2022
Could polyphenol intake affect Alzheimer’s disease risk?
The intake of certain polyphenols may be tied to a reduced risk of Alzheimer’s disease and related dementias (ADRDs) particularly in Black individuals, according to a study from the US presented at Nutrition 2022.
Could polyphenol intake affect Alzheimer’s disease risk?
28 Jul 2022
Secondary analysis boosts potential of atogepant for migraine prophylaxis in adults
In the secondary analysis of the phase III ADVANCE trial, responder rates were markedly higher with atogepant irrespective of dose than with placebo in adults with migraine.